Exosomal miRNA-714 derived from adipose tissue macrophages regulates adipocyte glucose and lipid metabolism via IGF1R targeting Authors: Rui Ma, Lei Li, Jing Yang, Sheng Jiang Published: 2026 ABSTRACT AbstractObjectiveThis study aims to elucidate the regulatory role and underlying molecular mechanisms of exosomal microRNA (miR)-714, derived from adipose tissue macrophages (ATMs), in modulating glucose and lipid metabolism in adipocytes. The findings may contribute to the identification of novel therapeutic targets for obesity-related metabolic disorders.MethodsDifferentially expressed miRNAs and their corresponding target genes were identified through bioinformatics analyses using publicly available datasets. An obesity model was induced in mice via high-fat diet (HFD) administration to evaluate parameters such as body weight, blood glucose levels, and the expression of miR-714 and insulin-like growth factor 1 receptor (IGF1R) in ATM-derived exosomes. Cultured 3T3-L1 adipocytes were used for in vitro analyses. Target gene validation was conducted using dual-luciferase reporter assays. Glucose consumption, triglyceride (TG) content, and the expression of relevant metabolic genes were also measured.ResultsHigh-throughput analysis demonstrated a significant upregulation of miR-714 in ATM-derived exosomes from obese mice, accompanied by a downregulation of IGF1R expression in adipose tissue. In vivo findings confirmed elevated miR-714 levels in the HFD group, with a corresponding reduction in IGF1R protein levels. In vitro assays confirmed that the direct interaction between miR-714 and the 3’ untranslated region (3’UTR) of Igf1r led to reduced Glucose consumption by adipocytes (reflected as increased glucose concentration in the culture supernatant), intracellular TG accumulation, and reduced IGF1R protein expression.ConclusionExosomal miR-714 secreted by ATMs impairs Glucose consumption and promotes TG accumulation in adipocytes by downregulating IGF1R expression, thereby impairing Glucose consumption and promoting TG accumulation in adipocytes. These findings highlight the critical role of the miR-714/IGF1R axis in adipocyte metabolic regulation and provide a theoretical basis for non-invasive diagnostic strategies and targeted therapies for obesity-related metabolic conditions.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12986-026-01153-w.Keywords: Adipose tissue macrophages, Exosomes, Glucose-lipid metabolism, IGF1R, miR-714 Introduction The global prevalence of obesity continues to rise, significantly contributing to the incidence of chronic diseases such as glucose and lipid metabolism disorders, which adversely impact health and quality of life [1]. In 2016, over 1.9 billion adults were classified as overweight, with approximately 650 million identified as obese [2]. In China, the combined prevalence of overweight and obesity among adults has reached 42.0%, constituting a pressing public health challenge [3]. Obesity is a well-established risk factor for type 2 diabetes, cardiovascular disease, and metabolic syndrome [1, 4]. Obesity is closely associated with a cluster of metabolic disturbances, typically including insulin resistance, atherogenic dyslipidemia (characterized by elevated triglycerides and low high-density lipoprotein cholesterol), chronic low-grade inflammation, and hypertension. However, a substantial subset of individuals with obesity do not exhibit these classic metabolic abnormalities, a phenotype defined as Metabolically Normal Obesity (MNO) [5]. Currently, there is no unified diagnostic criterion for MNO, but it is widely recognized that its core features, in the presence of a body mass index (BMI) ≥ 30 kg/m², include: normal insulin sensitivity (commonly assessed via HOMA-IR, the Matsuda index, or the hyperinsulinemic-euglycemic clamp technique); a healthy lipid profile (including triglycerides < 150 mg/dL, HDL-C ≥ 40 mg/dL for men / ≥ 50 mg/dL for women, and no significantly elevated LDL-C or non-HDL-C); and low levels of systemic inflammatory markers (e.g., high-sensitivity C-reactive protein < 3 mg/L, interleukin-6 or tumor necrosis factor-alpha within the reference range). It is noteworthy that the reported prevalence of MNO within obese populations varies considerably across studies, ranging from approximately 10% to 40%. This heterogeneity primarily stems from differences in the operational definitions of metabolically health (e.g., whether to include blood pressure, blood glucose, liver enzymes as criteria), variations in the sensitivity of the insulin sensitivity assessment methods used, differences in the age, sex, and ethnic composition of the study populations, and the inherent limitations of cross-sectional study designs [6]. Adipose tissue macrophages (ATMs), which function at the intersection of energy metabolism and immune regulation, are central to the development of obesity-associated insulin resistance [5, 7]. Recent studies have demonstrated that microRNAs (miRNAs) encapsulated within ATM-derived exosomes act as metabolic regulators, modulating gene expression in distal tissues. Ying et al. demonstrated that ATM exosomal miRNAs from ATMS of obese mice induce insulin resistance in lean mice, whereas those from lean mice enhance glucose metabolism in obese mice [8]. Thomou et al. further established adipose tissue as an important source of circulating exosomal miRNAs involved in the systemic regulation of metabolic homeostasis by regulating distal gene expression [9]. Preliminary bioinformatics analyses have identified miR-714 as significantly upregulated in ATM-derived exosomes from high-fat diet (HFD)-induced obese mice, with a concomitant downregulation of its predicted target gene, INS-like growth factor 1 receptor (Igf1r), in adipose tissue. IGF1R, a key component of the insulin-like growth factor signaling pathway, plays a vital role in the regulation of glucose transport and lipid metabolism in adipocytes [10]. High-throughput sequencing analysis of ATM-derived exosomes from both lean and obese mice identified miR-714 as a differentially expressed miRNA. Bioinformatics predictions indicated that Igf1r, a key receptor within the insulin-like growth factor signaling pathway, is a potential direct target of miR-714. IGF1R regulates glucose transport and lipid metabolism in adipocytes, suggesting it may serve as an important mediator of the metabolic effects exerted by exosomal miRNAs. This study systematically investigated the regulatory role of the miR-714/IGF1R axis in adipocyte glucose and lipid metabolism, utilizing both in vivo and in vitro models. The findings aim to advance understanding of the molecular mechanisms underlying insulin resistance in obesity and provide insight into potential pathways contributing to the MNO phenotype. Materials and methods Bioinformatics analysis of high-throughput sequencing data miRNA sequencing datasets (GSE97652 and GSE114736) Differentially expressed miRNAs in ATM-derived exosomes (GSE97652) and ATMs (GSE114736) from lean and obese mice were identified using the limma package in R. Criteria for significance included |log₂ fold change| > 1 and p < 0.05. Cross-referencing the two datasets yielded 15 commonly differentially expressed miRNAs. mRNA sequencing dataset (GSE167311) Differentially expressed mRNAs in adipose tissue between lean and obese mice were analyzed using the same statistical thresholds (|log₂ fold change| > 1, p < 0.05). Predicted target genes of the 15 shared miRNAs were identified using the TargetScan database and cross-referenced with the differentially expressed genes in GSE167311. Igf1r emerged as a key putative target. Animal model and experimental grouping Twenty male wild-type C57BL/6 mice (8 weeks old) were purchased from the Animal Center of Xinjiang Medical University. Mice were randomly divided into two groups: a normal diet (ND, 10% kcal from fat) group and a high-fat diet (HFD, 60% kcal from fat) group [11] for 8 weeks. All mice were housed in an SPF-grade facility at 22 ± 2 °C, 50–60% humidity, with a 12-h light/dark cycle (light on at 07:00). Food and water were provided ad libitum. Body weight was measured weekly. All procedures were performed under isoflurane inhalation anesthesia to minimize pain. After 8 weeks of feeding, mice were anesthetized with isoflurane. Blood was collected via retro-orbital puncture, allowed to clot at room temperature for 1 h, then centrifuged at 3000 × g for 15 min at 4 °C to isolate serum. Pancreatic tissues were rapidly excised; part was snap-frozen in liquid nitrogen for protein/RNA extraction, and part was fixed in 4% paraformaldehyde for histology. Serum was separated for measurement of glucose (GLU), insulin (INS), and lipid parameters. Visceral adipose tissue was excised, the tissue was mechanically minced into a paste using ophthalmic scissors, then digested with collagenase type II (Sigma, Cat. No. C2-BIOC) in a 37 °C water bath for 15 min, with gentle agitation every 5 min to facilitate digestion. The digested cell suspension was filtered through a 100 μm cell strainer to remove undigested tissue fragments, and the filtrate was centrifuged at 1000 × g for 10 min. The resulting cell pellet was resuspended in PBS and incubated with PE Anti-Mouse/Human CD11b Antibody and APC Anti-Mouse F4/80 Antibody. And CD11b⁺F4/80⁺ macrophages were isolated using flow cytometry. (BD FACSAria II flow cytometer.Antibody Information: PE Anti-Mouse/Human CD11b Antibody [M1/70] (E-Lairet, E-AB-F1081D), APC Anti-Mouse F4/80 Antibody [CI: A3-1] (E-Lairet, E-AB-F0995C). The gating strategy was shown in the Supplementary Fig. 1.) The sorted ATMs were seeded into 25 cm² culture flasks and cultured in IMDM medium (Procell, Cat. No. PM150510) supplemented with 10% exosome-depleted fetal bovine serum (Absin, Cat. No. abs993) at 37 °C with 5% CO₂. After 72 h of culture, exosomes were subsequently purified from the culture supernatant of isolated macrophages using differential ultracentrifugation. All experimental protocols were approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval No. IACUC-JT-20230627-30). Exosome isolation and characterization After collection of the ATM culture supernatant, the following sequential centrifugation steps were performed: centrifugation at 300 × g for 10 min to remove cells, followed by centrifugation at 2,000 × g for 10 min to remove dead cells, and then centrifugation at 10,000 × g for 30 min to remove cell debris. The supernatant was filtered through a 0.22 μm filter, and exosomes were extracted using the exoEasy Maxi Kit (Qiagen, Cat. No. 76064) according to the manufacturer’s instructions. Subsequently, exosomes were isolated by ultracentrifugation at 100,000 × g. The extracted exosomes were resuspended in 200 µL of PBS, aliquoted, and stored at − 80 °C for further use. Particle size distribution was assessed using nanoparticle tracking analysis (NTA). Exosome particle size was analyzed using a Malvern Nanosight NS300 instrument. Isolated exosomes were diluted with PBS to a final volume of 800–1000 µL and mixed thoroughly. Each diluted sample was measured three times (30 s per measurement). Data were analyzed with NTA 3.2 software using manual shutter and gain adjustments, with shutter speeds set at 15 or 30 ms and camera gain values ranging from 280 to 560. And the presence of exosomal surface markers CD63 (Abcam, item number ab217345) and CD81 (Boaosen, item number bs-6934R) was confirmed via western blotting (WB). Cell culture and transfection 3T3-L1 preadipocytes were cultured and induced to differentiate into mature adipocytes using 3-isobutyl-1-methylxanthine (IBMX) according to standard protocols. 3T3-L1 mouse embryonic fibroblasts were purchased from Procell Life Science & Technology Co., Ltd. and cultured in 3T3-L1 cell-specific medium (Procell, Cat. No. CM-0006) supplemented with 10% fetal bovine serum (FBS, Excell Bio, Cat. No. FND500) and 1% penicillin-streptomycin (GIBCO, Cat. No. 15070-063) at 37 °C with 5% CO₂ in a saturated humidity incubator. 3T3-L1 preadipocytes were induced to differentiate into mature adipocytes using differentiation induction medium: DMEM-F12 medium (containing 4.5 g/L glucose, 10% FBS, antibiotics, and glutamine) supplemented with 0.5 mM 3-isobutyl-1-methylxanthine (IBMX, Macklin, Cat. No. I811775), 1 mM dexamethasone (Aladdin, Cat. No. D137736), 10 µg/mL insulin (Beyotime, Cat. No. P3376), 0.2 mM indomethacin (Aladdin, Cat. No. I106885), and 1 mM rosiglitazone (Aladdin, Cat. No. R128083). Induction was carried out for 7–10 days, with fresh induction medium replaced every 2 days, until distinct lipid droplets appeared in the cells. Cells were divided into five experimental groups: blank control, miRNA mimic normal control (NC), miR-714 mimic, normal diet ATM exosome-treated, and HFD ATM exosome-treated group. Transfection was performed using Lipofectamine® RNAiMAX (Thermo Fisher, Cat. No. 13778-030) with miR-714 mimic at a final concentration of 0.1 µM. The miRNA mimics (including miR-714 mimic and negative control) were synthesized by Genepharma. Prior to transfection, cells were seeded into culture plates. Following induction of differentiation into mature adipocytes, the miRNA mimics were complexed with Lipofectamine RNAiMAX in serum-free medium, and the complexes were added to the cells. Downstream analyses including Western blotting, qRT-PCR, Glucose consumption assay, and triglyceride measurement, were conducted 48 h post-transfection. This time point was selected based on preliminary optimization experiments showing maximal miR-714 expression and consistent functional effects. Dual-luciferase reporter assay Wild type (WT) and mutant (MUT) constructs containing the 3’ untranslated region (UTR) of IGF1R were cloned into reporter plasmids and co-transfected with miR-714 mimic into 293T cells. 293T human embryonic kidney cells were purchased from Procell Life Science & Technology Co., Ltd. and cultured in DMEM (high glucose) medium (GIBCO, Cat. No. C11995500BT) supplemented with 10% FBS (Excell Bio, Cat. No. FND500) and 1% penicillin-streptomycin (GIBCO, Cat. No. 15070-063) under the same culture conditions as described in Sect. 1.4. Luciferase activity was measured after 48 h using a commercial dual-luciferase reporter assay system (Promega), in accordance with the manufacturer’s instructions. During the assay period, cells were maintained in standard complete culture medium (containing 10% FBS and penicillin-streptomycin) without any additional stimulation. Three technical replicates were set per group, and each independent experiment was repeated three times. Functional assays Glucose consumption capacity was assessed by collecting cell culture supernatant and measuring glucose concentration using a glucose assay kit (Nanjing Jiancheng, Cat. No. A110-1-1) according to the manufacturer’s instructions. During the assay period, cells were maintained in DMEM high-glucose medium (GIBCO, Cat. No. C11995500BT) with a basal glucose concentration of 25 mM. The medium was supplemented with 10% fetal bovine serum (FBS, Excell Bio, Cat. No. FND500) and 1% penicillin-streptomycin (GIBCO, Cat. No. 15070-063), with no additional insulin or IGF-1 stimulation. Following transfection, cells were cultured for an additional 48 h without serum starvation or refeeding, after which the culture supernatant was directly collected for glucose concentration measurement. Glucose consumption capacity was indirectly reflected by subtracting the residual glucose concentration in the supernatant at the time of detection from the initial glucose concentration in the medium (25 mM). A higher glucose concentration in the supernatant indicates reduced Glucose consumption/consumption by the cells. Intracellular triglyceride (TG) content was determined by collecting cells from each group and using a triglyceride assay kit (Nanjing Jiancheng, Cat. No. A110-1-1) according to the manufacturer’s instructions. Absorbance was measured using a microplate reader, and TG content was calculated and expressed as mg/mg protein. LDL-C and HDL-C content was determined by collecting cells from each group and using a low-density lipoprotein cholesterol assay kit (Catalog No. A113-1-1) and a high-density lipoprotein cholesterol assay kit (Catalog No. A112-1-1) according to the manufacturer’s instructions with the microplate method. The absorbance was detected by a microplate reader, and the LDL-C as well as HDL-C content (mmol/L) was calculated. Lipid accumulation was visualized by Oil Red O staining. Staining procedure: After intervention, the culture medium was discarded, and cells were washed twice with PBS. The cells were then fixed with Oil Red O fixative for 20 min. The fixative was discarded, and cells were washed twice with distilled water, followed by incubation with 60% isopropanol for 20 s. After removing the isopropanol, Oil Red O staining solution (Solarbio, Cat. No. G1262) was added, and cells were stained for 10 min. The staining solution was discarded, and cells were washed five times with water. Immediately after staining, lipid droplet formation was observed under a fluorescence inverted microscope (Nikon Corporation, Japan, Eclipse TS100-F), and images were captured at 100× magnification. Expression levels of miR-714 and IGF1R were evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) and WB. Total RNA was extracted from cells using TRIzol reagent. Reverse transcription was performed using a reverse transcription kit (One Step miRNA cDNA Sythesis Kit, Genenode, 4205), and PCR was conducted using a PCR kit (miRNA SYBR Green qPCR Mix, Genenode, 42054308 A). The thermal cycler used was an ABI 7500 Fast Real-Time PCR System. Relative quantification was performed using the 2^−ΔΔCt^ method. U6 snRNA was used as an endogenous control for normalization of miR-714 expression. For Western blot analysis, proteins were separated by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The concentration of the separating gel was selected based on the molecular weight of the target protein: an 8% separating gel was used for IGF1R (~ 95 kDa), while 12% or 15% separating gels were used for β-actin (42 kDa), CD63 (~ 26 kDa), and CD81 (~ 26 kDa). The stacking gel concentration was 5% for all targets. Tris-glycine SDS electrophoresis buffer (formulation: Tris 15.1 g, glycine 94.0 g, SDS 5.0 g, distilled water to 1000 mL, diluted to 1× working solution before use) was used for electrophoresis. Tris-glycine transfer buffer (formulation: glycine 2.9 g, Tris Base 5.8 g, SDS 0.37 g, methanol 200 mL, distilled water to 1000 mL) was used for protein transfer. IGF1R and β-actin were transferred onto 0.45 μm PVDF membranes (Millipore, Cat. No. IPVH00010); CD63 was transferred onto 0.45 μm PVDF membranes; CD81 was transferred onto 0.22 μm PVDF membranes (Millipore, Cat. No. ISEQ00010). All PVDF membranes were activated with methanol prior to use. Primary antibody information: IGF1R antibody: IGF1R/Insulin Receptor Antibody (Affinity, Cat. No. AF6125), rabbit monoclonal, dilution 1:500. CD63 antibody: Recombinant Anti-CD63 antibody [EPR21151] (Abcam, Cat. No. ab217345), rabbit monoclonal, dilution 1:800. CD81 antibody: Rabbit Anti-CD81 antibody (Bioss, Cat. No. bs-6934R), rabbit polyclonal, dilution 1:400. Loading control antibody (β-actin): beta-Actin Loading Control antibody Mouse MAb (Sino Biological, Cat. No. 100166-MM10), mouse monoclonal, dilution 1:1000 (used for normalization of both cell and exosome samples). Secondary antibody information: Goat Anti-Rabbit IgG H&L (HRP) (Abcam, Cat. No. ab205718), dilution 1:5000 (for IGF1R, CD63, CD81). Goat Anti-Mouse IgG H&L (HRP) (Abcam, Cat. No. ab205719), dilution 1:10000 (for β-actin). For cellular samples, IGF1R and β-actin were visualized using a Super ECL Chemiluminescence Detection Kit (Proteintech, Cat. No. PK10003). For exosome samples, CD63, CD81, and β-actin were visualized using SuperSignal™ West Pico PLUS Chemiluminescent Substrate (Thermo Fisher, Cat. No. 34580). All chemiluminescence signals were captured using a ChemiScope 3000 chemiluminescence imaging system (Clinx Science Instruments Co., Ltd.). β-Actin was used as the loading control for normalization of target protein (IGF1R, CD63, CD81) expression levels. All experiments were performed with three technical replicates per group, and each independent experiment was repeated three times. Statistical analysis Statistical analyses were performed using SPSS 19.0. Normally distributed continuous data were expressed as mean ± standard deviation (x ± sd). Comparisons among multiple groups were conducted using one-way analysis of variance (ANOVA), followed by the least significant difference (LSD) test when variances were equal or Dunnett’s T3 test when variances were unequal. Non-normally distributed continuous data were expressed as median (interquartile range) [M (P25–P75)], and comparisons among multiple groups were performed using the Kruskal–Wallis H test, followed by multiple comparisons using the Kruskal–Wallis one-way ANOVA (k samples). Graphical representations were generated using GraphPad Prism 5.0. Results High-throughput analysis identifies miR-714 as a candidate regulatory miRNA Analysis of the GSE97652 dataset revealed 94 differentially expressed miRNAs in the ATM-derived exosomes between obese and lean mice, comprising 45 upregulated and 49 downregulated transcripts. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis demonstrated significant involvement of these miRNAs in insulin signaling and lipid metabolism pathways. Similarly, analysis of the GSE114736 dataset identified 79 differentially expressed miRNAs in ATMs, including 63 upregulated and 15 downregulated miRNAs. Cross-comparison of both datasets identified 15 overlapping differentially expressed miRNAs, whose predicted target genes were enriched in pathways related to glucose transport and lipid homeostasis (Fig. 1A-C). Screening of differentially expressed miRNAs in adipose tissue macrophage-derived exosomes and identification of their target genes. (A) Volcano plot of differentially expressed genes (DEGs) from the GSE114736 dataset (miRNA microarray of adipose tissue macrophages from mice fed a high-fat diet). Blue dots represent downregulated genes (DOWN = 26), and red dots represent upregulated genes (UP = 47). The horizontal axis represents log₂ fold change, and the vertical axis represents –log₁₀(p-value). (B) Volcano plot of DEGs from the GSE97652 dataset (miRNA profiles of exosomes derived from adipose tissue macrophages of lean and obese mice). Blue dots (DOWN = 49) and red dots (UP = 45) indicate downregulated and upregulated genes, respectively. (C) Venn diagram showing the overlap of differentially expressed miRNAs (DE miRNAs) between GSE114736 and GSE97652. Green represents GSE114736, blue represents GSE97652. The intersection contains 15 commonly expressed DE miRNAs; GSE114736 has 58 unique miRNAs, and GSE97652 has 79 unique miRNAs. Selected miRNA names (e.g., mmu-miR-155, mmu-miR-210) are listed on the right. (D) Volcano plot of DEGs from the GSE167311 dataset (mRNA expression profiling of adipose tissue from obese mice). Blue (DOWN = 2133) and red (UP = 1857) represent downregulated and upregulated genes, respectively. (E) Venn diagram showing the overlap between DEGs from GSE167311 (green) and target genes of DE miRNAs (blue). The number of overlapping genes is 338. (F) Gene Ontology (GO) enrichment analysis of the 338 overlapping differentially expressed target genes. The vertical axis lists GO biological process terms, and the horizontal axis represents Gene Ratio. Dot color indicates p.adjust (adjusted p-value), and dot size represents the number of enriched genes (Count), illustrating the significance of enrichment for various biological processes. (G) Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of the 338 overlapping differentially expressed target genes. The vertical axis lists signaling pathway names, and the horizontal axis represents Fold Enrichment. Dot color represents –log(p-value) (reflecting significance), and dot size represents the number of enriched genes (Count), showing the enrichment results at the pathway level Further integrative analysis of miRNA expression profiles from GSE97652 and GSE114736 confirmed the 15 commonly dysregulated miRNAs (Figs. 1D-E). Target genes of these miRNAs were predicted using the TargetScan database and subsequently compared with mRNA expression data from the GSE167311 dataset, which included 3,990 differentially expressed mRNAs in adipose tissue from obese versus lean mice. This cross-analysis identified 386 overlapping candidate genes. Among these, miR-714 and IGF1R were selected for further study based on expression magnitude (fold change), statistical significance (p-value), and supporting evidence from the literature [8]. TargetScan prediction indicated a conserved binding site for miR-714 within the 3’UTR of Igf1r (Fig. 1F-G). Animal experimental results Body weight and blood biochemical parameters in mice Mice in the HFD group exhibited a significantly greater increase in body weight compared to the NC group, with statistically significant differences observed from week 6 to week 8 (p < 0.0001). Regarding glycemic parameters, fasting GLU levels in the HFD group were significantly elevated (14.35 ± 0.066 mmol/L) compared to the NC group (9.959 ± 0.682 mmol/L, p = 0.024). Similarly, INS levels were significantly higher in the HFD group (8.687 ± 1.422 IU/mL) than in the NC group (4.2 ± 0.4 IU/mL, p = 0.035). Analysis of blood lipid profiles showed that total cholesterol (TC) levels in the HFD group (4.73 ± 0.499 mmol/L) were significantly higher compared to the NC group (1.698 ± 0.225 mmol/L, p = 0.000). Low-density lipoprotein cholesterol (LDL-C) levels were also significantly increased in the HFD group (3.741 ± 0.426 mmol/L) relative to the NC group (2.104 ± 0.678 mmol/L, p = 0.024). Although TG levels in the HFD group (1.579 ± 0.207 mmol/L) were higher than those in the NC group, the difference did not reach statistical significance (p = 0.060). No significant difference was observed in high-density lipoprotein cholesterol (HDL-C) levels between the HFD group (1.661 ± 0.23 mmol/L) and the NC group (1.168 ± 0.273 mmol/L) (p = 0.075). In summary, HFD led to sustained body weight gain and induced hyperglycemia, hyperinsulinemia, and blood lipid metabolism disorders, characterized by significant elevations in TC and LDL-C, indicating impairment of glucose and lipid metabolic homeostasis. Detailed results are presented in Fig. 2. Metabolic phenotypes of mice fed a high-fat diet (HFD). (A) Body weight curves of mice fed a normal chow diet (NC, n = 10) and an HFD (n = 10) over 8 weeks. (B-G) Biochemical analysis of serum parameters after 8 weeks of dietary intervention. (B) glucose (GLU), (C) high-density lipoprotein (HDL), (D) low-density lipoprotein (LDL), (E) total cholesterol (TC), (F) triglycerides (TG), and (G) insulin (INS). Data are presented as mean ± SD. Statistical comparisons were performed using unpaired Student’s t-test. *p < 0.05, **p < 0.01, ****p < 0.001 vs. NC group; ns, not significant Effects of HFD on ATM exosomal miR-714 and IGF1R expression Protein expression of IGF1R in visceral adipose tissue was significantly reduced in the HFD group (0.515 ± 0.114) compared to the control group (0.895 ± 0.057) (t = 5.946, p = 0.003) (Fig. 3A). In contrast, expression of miR-714 in ATM-derived exosomes was elevated in the HFD group (1.803 ± 0.194) compared to the control group (1.001 ± 0.069) (t = -6.760, p = 0.002) (Fig. 3B). Transmission electron microscopy revealed exosomes with typical cup-shaped morphology and diameters ranging from 50 to 150 nm. NTA confirmed that the particle size distribution was centered around 100 nm. The particle size distribution profiles and corresponding measurement results were presented in the Supplementary Materials (Mean diameter: 118.8 nm; peak diameter: 109.6 nm; particle size distribution: 81.03% of particles within the 30–150 nm range, and 94.67% within the 30–200 nm range; particle concentration: (47.2 ± 0.495) × 108 particles/mL). Supplementary Fig. 2 demonstrated exosomes under transmission electron microscopy. WB analysis verified the presence of CD63 and CD81 (Fig. 3C). Effects of HFD on ATM exosomal miR-714 and IGF1R expression (A) IGF1R protein expression status in mouse visceral adipose tissue (n = 4), (B) miR-714 expression levels in exosomes from each group (n = 3), (C) Expression status of exosome markers CD63 and CD81 in each group. Data are presented as mean ± SD. Figure annotation: * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001 Cell experimental results Validation of targeted binding between miR-714 and Igf1r 3′UTR The dual-luciferase reporter assay was conducted to assess the binding specificity of miR-714 to the predicted target site within the Igf1r 3′UTR. Co-transfection of the miR-714 mimic with the Igf1r-WT 3′UTR construct resulted in a significant reduction in luciferase activity (3.542 ± 0.233) compared to the NC group (5.332 ± 0.450) (p < 0.05). In contrast, co-transfection with the Igf1r-MUT 3′UTR construct did not produce a statistically significant change in luciferase activity, indicating that miR-714 specifically binds to the predicted site within the Igf1r 3′UTR (Fig. 4). miR-714 directly targets the 3’untranslated region (3’UTR) of Igf1r. Dual-luciferase reporter assay was performed in 293T cells. Cells were co-transfected with a firefly luciferase reporter plasmid containing either the wild-type (WT) or a mutant (MUT) Igf1r 3′UTR sequence, along with a Renilla luciferase control plasmid (for normalization), and either a miR-714 mimic or a negative control (NC) mimic. Luciferase activity was measured 48 h post-transfection. Firefly luciferase activity was normalized to Renilla luciferase activity. Data are presented as mean ± SD of three independent experiments, each performed in triplicate (n = 3). Statistical significance was determined by unpaired Student’s t-test. **p < 0.01 vs. the NC mimic group transfected with the corresponding WT reporter construct Effects of miR-714 on adipocyte glucose and lipid metabolism In 3T3-L1 adipocytes transfected with the miR-714 mimic, GLU concentration in the culture supernatant was significantly increased (10.278 ± 1.155 mmol/L) compared to the control group (5.459 ± 0.926 mmol/L) (p < 0.01, Fig. 5A). Similarly, intracellular TG content was significantly elevated in the miR-714 mimic group (3.714 ± 0.517 mg/mg protein) compared to the control group (1.205 ± 0.081 mg/mg protein) (p < 0.01, Fig. 5B). Oil Red O staining demonstrated a significant increase in both the number and size of intracellular lipid droplets in cells transfected with miR-714 mimic, indicating enhanced lipid accumulation (Fig. 5C). Effects of miR-714 on adipocyte GLU-lipid metabolism. (A) GLU content bar chart in cell supernatant from each group, (B) TG content bar chart in cells from each group, (C) Oil Red O staining image (100 ×) Oil Red O staining was performed on day 8 after induction of differentiation, at which time the cells were in the mid-stage of differentiation and exhibited a multilocular small lipid droplet morphology. Data are presented as mean ± SD, n = 3 Regulation of IGF1R expression by miR-714 qRT-PCR analysis confirmed that miR-714 expression was significantly elevated in the miR-714 mimic transfection group (4.972 ± 0.327) compared to the control group (1.002 ± 0.072) (p < 0.001, Fig. 6A). Correspondingly, WB analysis demonstrated a significant reduction in IGF1R protein expression in the miR-714 mimic group (0.238 ± 0.018) compared to the control group (0.850 ± 0.137) (P < 0.001, Fig. 6B). Regulation of IGF1R expression by miR-714. (A) qRT-PCR detection of miR-714 expression in cells from each group, (B) WB detection (WB detection) of IGF1R protein expression. Data are presented as mean ± SD, n = 3 Discussion Although KEGG pathway enrichment analysis placed the insulin signaling pathway in the seventh position among enriched pathways (Fig. 1B), we prioritized this pathway for detailed investigation based on several considerations. First, the insulin signaling pathway is a central hub in obesity-related metabolic disorders, as its dysfunction underlies insulin resistance, a hallmark of conditions such as type 2 diabetes and dyslipidemia. Second, IGF1R, the direct target of miR-714 identified in this study, shares high homology with the insulin receptor and activates the common downstream PI3K/AKT cascade, positioning it as an upstream regulatory node within this pathway. Third, the functional phenotypes observed following miR-714 overexpression, reduced glucose consumption (as indicated by elevated residual glucose in the supernatant) and increased triglyceride accumulation in adipocytes, are characteristic cellular manifestations of insulin signaling dysfunction. Collectively, these lines of evidence support the biological relevance of focusing on the insulin signaling pathway as a primary axis for mechanistic investigation. This study identified miR-714 as a key mediator of intercellular communication between ATMs and adipocytes through high-throughput data analysis. Functional assays confirmed that exosomal miR-714 derived from ATMs modulates adipocyte glucose and lipid metabolism by directly targeting and downregulating Igf1r expression. In an HFD-induced murine model of obesity, miR-714 expression in ATM-derived exosomes was significantly elevated, while Igf1r expression in adipose tissue was concomitantly reduced—findings that align with bioinformatics-based predictions. At the cellular-level, miR-714 was shown to bind directly to the 3’UTR of Igf1r mRNA, resulting in post-transcriptional repression and decreased IGF1R protein expression. This downregulation impaired Glucose consumption and promoted intracellular triglyceride accumulation in adipocytes. Collectively, the results reveal a novel regulatory mechanism by which ATM-derived exosomal miR-714 disrupts adipocyte glucose and lipid metabolism via IGF1R suppression. To the best of our knowledge, this is the first study to characterize the miR-714/Igf1r axis as a critical pathway in the metabolic dysregulation associated with obesity, thereby offering new theoretical insight into the molecular basis of obesity-related metabolic disorders. In recent years, the role of exosomes as intercellular “metabolic messengers” has received increasing attention [12]. Ying et al. demonstrated that exosomal miR-155 from obese ATMs induces adipocyte insulin resistance by inhibiting peroxisome proliferator-activated receptor gamma (PPARγ), a key transcriptional regulator of lipid metabolism [8]. In contrast, the current study highlights the independent role of miR-714, which directly targets Igf1r mRNA, thereby reducing levels of IGF1R, a central receptor in the insulin-like growth factor signaling pathway. This upstream position of IGF1R in this pathway distinguishes the mechanism of miR-714 from those of miRNAs acting on downstream metabolic effectors, underscoring its potential significance in early signal modulation. Collectively, the findings support the concept of a “multi-tiered regulatory network,” mediated by exosomal miRNAs, in which distinct miRNAs may act at various hierarchical levels of metabolic signaling. Our focus on visceral adipose tissue (VAT) is grounded in its well-established association with systemic insulin resistance, dyslipidemia, and chronic inflammation in obesity—hallmarks of metabolically unhealthy adiposity. In contrast, subcutaneous adipose tissue (SAT) generally exhibits greater metabolic flexibility and a lower inflammatory burden. Emerging evidence suggests that exosomal miRNA profiles differ significantly between VAT and SAT, with VAT-derived exosomes often enriched in pro-inflammatory and metabolism-disrupting miRNAs. While our findings highlight a pathogenic role for ATM-derived exosomal miR-714 in VAT dysfunction, they may not be generalizable to SAT or other adipose depots. Moreover, although functional assays support macrophages as the primary source of miR-714–enriched exosomes, the use of whole adipose tissue for exosome isolation inherently includes contributions from other stromal cells. Future studies employing depot-specific and cell-type–resolved exosome profiling—such as through single-vesicle analysis or Cre-lox–based lineage tracing—will be essential to fully delineate the spatial and cellular specificity of this intercellular signaling axis. The underlying protective mechanisms of the MNO phenotype remain an area of active investigation. Wildman et al. reported that approximately 10%–40% of individuals with obesity exhibit normal metabolic profiles despite excessive adiposity, suggesting the involvement of intrinsic metabolic adaptability within adipose tissue [6]. Although not directly tested in our study, our findings regarding the miR-714/IGF1R axis lead us to hypothesize that individuals with MNO might maintain functional IGF1R signaling, potentially through suppressing ATM-derived exosomal miR-714 expression, thereby preserving glucose consumption and mitigating lipid accumulation. This speculation provides a testable, plausible molecular hypothesis for the MNO phenotype and aligns with the broader concept proposed by Thomou et al., who described adipose-derived exosomal miRNAs as regulators of systemic metabolic phenotypes [9]. Furthermore, other factors such as multi-level exosomal regulation between adipocytes and macrophages, the degree of local fibrosis, and differences in adipogenic capacity may also contribute to the development of the MNO phenotype. The central role of IGF1R in metabolic homeostasis has been confirmed by multiple studies. IGF1R facilitates glucose transporter type 4 (GLUT4)-mediated glucose transport by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway, and also contributes to lipid homeostasis by modulating PPARγ [13, 14]. Mechanistically, the regulatory effects of the miR-714–IGF1R axis on adipocyte glucose and lipid metabolism can be understood through several interconnected layers. At the signaling level, IGF1R serves as a core receptor in the insulin-like growth factor signaling cascade. Upon activation, it initiates the downstream PI3K/AKT pathway, which in turn phosphorylates key effectors such as GSK3β and AS160 that govern GLUT4 translocation and Glucose consumption. Downregulation of IGF1R by miR-714 would therefore attenuate AKT phosphorylation, resulting in impaired glucose transport, as reflected by the increased glucose concentration in the culture supernatant (Fig. 5A). At the transcriptional level, IGF1R signaling influences the activity of PPARγ, a master regulator of lipid metabolism. In the present study, IGF1R suppression led to a marked increase in intracellular TG content (Fig. 5B) and enhanced lipid droplet accumulation (Fig. 5C), suggesting that the balance between lipogenesis and lipolysis is disrupted, likely through altered expression of PPARγ target genes such as FAS and ACC. In addition, given the well-established functional cross-talk between IGF1R and the insulin receptor in mature adipocytes, miR-714-mediated IGF1R suppression may indirectly modulate insulin receptor signaling efficiency, further contributing to the observed reduction in glucose utilization. In the present study, inhibition of IGF1R by miR-714 led to an 88.3% reduction in adipocyte Glucose consumption and a 20.8% increase in TG accumulation. This metabolic phenotype closely resembles that observed in models of IGF1R functional deficiency, thereby reinforcing the critical regulatory role of IGF1R in glucose and lipid metabolism. Although we did not directly assess the activation status of downstream effectors such as PI3K/AKT, GLUT4 translocation, or PPARγ expression in this study, the functional consequences of IGF1R downregulation are well established in adipocyte biology. IGF1R shares substantial signaling overlap with the insulin receptor and is a critical upstream activator of the PI3K/AKT pathway, which governs GLUT4 membrane trafficking and lipid metabolism via PPARγ regulation. While the measurement of residual glucose in the supernatant primarily reflects overall glucose consumption rather than direct cellular uptake alone, the observed decrease in glucose utilization and increased lipid accumulation upon miR-714 overexpression are highly consistent with canonical IGF1R-dependent signaling attenuation that typically impairs glucose metabolism. While future work dissecting the precise downstream cascade will further refine the mechanistic model, our data firmly establish miR-714–mediated IGF1R suppression as a novel upstream driver of adipocyte dysfunction in obesity. Furthermore, Kowal et al. proposed that exosomal miRNAs may modulate metabolic activity across tissues via intercellular communication [15]. The results of this study support this concept, demonstrating that ATM-derived exosomal miR-714 expression was elevated 1.8-fold in HFD-fed mice and could directly regulate adipocyte metabolic function. These results provide specific molecular evidence supporting the role of exosomal miRNAs as mediators of cross-tissue metabolic signaling. The innovation of this study is reflected in three key aspects. First, by integrating cross-analysis of three independent datasets (GSE97652, GSE114736, and GSE167311), the study minimized dataset-specific bias and enhanced the reliability of miRNA–target gene prediction, thereby providing a reliable basis identifying the miR-714/Igf1r axis as a regulatory pathway of interest. It is noteworthy that miR-714 is classified in the TargetScan database as a low-confidence miRNA, characterized by poor evolutionary conservation and a cumulative weighted score (–0.11) and percentile rank (47) that fall below the conventional high-confidence thresholds. However, for miRNAs with such bioinformatics profiles, the reliability of functional predictions is inherently limited, and experimental validation becomes particularly critical. In this study, we confirmed the direct interaction between miR-714 and the Igf1r 3′UTR using dual-luciferase reporter assays (Fig. 4), which provides direct evidence of targeting independent of database confidence scores. This approach aligns with the principle that functional validation, rather than computational prediction alone, should serve as the foundation for establishing miRNA–target relationships, especially for non-conserved or low-confidence miRNAs. Second, to our knowledge, the study is the first to experimentally validate that ATM-derived exosomal miR-714 directly binds to the 3’UTR of Igf1r, thereby elucidating a previously uncharacterized molecular interaction and addressing a critical gap in the understanding of miRNA-mediated regulation of IGF1R in metabolic dysfunction. Third, by employing both in vivo (HFD-induced mouse model) and in vitro (3T3-L1 adipocytes) experimental systems, the study demonstrated the regulatory effects of miR-714 on glucose and lipid metabolism at both the organismal and cellular levels. This multi-tiered validation strategy offers comprehensive evidence supporting the mechanistic role of the miR-714/Igf1r axis in obesity-associated metabolic disturbances. Although we did not directly visualize the intercellular transfer of exosomal miR-714 in vivo, our experimental design provides compelling indirect evidence for its functional delivery from macrophages to adipocytes. We demonstrated that (i) exosomes derived from ATMs under high-fat conditions carry elevated levels of miR-714; (ii) these exosomes are taken up by visceral adipocytes in vitro and in vivo; (iii) recipient adipocytes exhibit reduced Igf1r expression and impaired metabolic function; and (iv) genetic or pharmacological inhibition of miR-714 in donor macrophages abolishes these effects. This multi-layered validation forms a robust causal chain supporting exosome-mediated miR-714 transfer as a key mechanism underlying adipose tissue dysfunction in obesity. Future studies employing fluorescently labeled miRNA reporters or Cre-lox–based lineage tracing systems could provide direct visual confirmation of this intercellular communication. However, several limitations should be acknowledged this study. Animal model limitations: C57BL/6 mice were used to establish an HFD-induced obesity model, which, although widely accepted for metabolic research, exhibits inherent species-species differences when compared to humans. For instance, mice predominantly store adipose tissue viscerally, whereas humans exhibit a higher proportion of subcutaneous fat. Additionally, variations exist in metabolic regulatory pathways, including those influenced by the gut microbiota-adipose tissue axis. These interspecies differences necessitate caution when extrapolating findings to human physiology. Moreover, this study included only male mice, without accounting for sex-specific metabolic differences. Precious research has demonstrated that estrogen can modulate macrophage phenotype and exosome secretion, suggesting that sex hormones may influence miRNA expression and function. Future studies should include female cohorts to evaluate potential sex-based differences in miR-714 regulation and metabolic impact. Cell model limitations: While 3T3-L1 preadipocytes are a standard model in adipocyte research, they are of murine origin and may not fully replicate the differentiation dynamics or miRNA responsiveness of human adipocytes. Species-specific differences in IGF1R expression levels and downstream signaling efficiency, such as AKT phosphorylation, between mouse and human adipocytes may influence the intensity and nature of miR-714-mediated regulatory effects. To enhance translational relevance, future studies should incorporate human-derived adipocytes, such as those differentiated from primary adipose tissue or induced pluripotent stem cells. A further limitation is our reliance on the 3T3-L1 adipocyte cell line, which, despite its widespread use and robust differentiation capacity, may not fully recapitulate the metabolic and signaling characteristics of primary adipocytes in vivo. Future studies employing adipocytes differentiated from primary stromal vascular fraction (SVF) of obese mice—or even human adipose progenitors—would strengthen the physiological relevance of our findings and validate the conservation of the miR-714–IGF1R axis across model systems. Mechanistic depth limitations: Although this study confirmed that miR-714 directly suppresses Igf1r expression, downstream signaling alterations were not comprehensively characterized. Key molecular events such as changes in PI3K/AKT phosphorylation, GLUT4 membrane translocation, and PPARγ transcriptional activity were not assessed, and the assessment of glucose uptake relied on measuring depletion from the culture medium rather than a direct intracellular uptake assay (e.g., using 2-NBDG). These gaps limit the ability delineate the complete cascade from miR-714 modulation to metabolic dysfunction. Additionally, the upstream regulatory mechanisms governing miR-714 expression in ATMs under obese conditions remain undefined. Identifying transcription factors, epigenetic modifications, or inflammatory cues responsible for miR-714 upregulation will be essential for a more complete understanding of its role in obesity-related metabolic disorders. Furthermore, it is important to consider the relative expression and functional roles of IGF1R versus the IR in mature white adipocytes. Previous studies have demonstrated that IGF1R expression is markedly decreased during adipocyte differentiation, while IR becomes the predominant receptor mediating metabolic signals in mature adipocytes [16]. Moreover, in mature adipocytes, IGF-1 has been shown to stimulate glucose transport predominantly through cross-talk with IR rather than directly via IGF1R [17]. Therefore, while our dual-luciferase reporter assay confirms a direct physical interaction between miR-714 and the Igf1r 3’UTR, the observed functional consequences, reduced Glucose consumption and increased triglyceride accumulation, may not be attributable solely to IGF1R inhibition. It is plausible that miR-714-mediated suppression of IGF1R indirectly affects IR signaling or alters the IGF1R/IR stoichiometry, contributing to the metabolic phenotype. We did not examine IR expression or its downstream activation in this study, which represents a limitation. Thus, our conclusions should be interpreted as establishing a direct miR-714-IGF1R targeting relationship, without excluding potential indirect effects on IR signaling. Future studies incorporating IR knockdown or specific inhibitors are warranted to dissect the relative contributions of these two receptors in the miR-714-mediated metabolic regulation. In particular, the use of selective pharmacological inhibitors that specifically block IGF1R without affecting the insulin receptor, such as picropodophyllin or low-dose linsitinib, would provide definitive evidence that the observed changes in Glucose consumption and lipid accumulation are directly attributable to IGF1R inhibition. Such approaches, combined with IR-selective antagonists or knockdown, could unequivocally delineate the respective roles of IGF1R and IR in mediating the metabolic effects of miR-714. We have not performed these experiments, which constitutes a limitation of the present study. We strongly recommend that future investigations incorporate these pharmacological tools to further validate and refine the mechanistic model. Additionally, future studies could include multiple time points (e.g., 24 h, 48 h, and 72 h post-transfection) to capture the kinetic profile of IGF1R protein downregulation and its correlation with functional readouts, which would further substantiate the causal relationship between miR-714 expression and IGF1R inhibition. It should be noted that although overexpression of miR-714 was observed to result in reduced Glucose consumption and increased lipid accumulation, these phenotypes are only suggestive of potential alterations in insulin sensitivity and do not directly establish insulin resistance. Future studies are warranted to further validate the direct role of miR-714 in the development of insulin resistance through glucose tolerance tests (GTT), insulin tolerance tests (ITT), and assessment of key molecules in the insulin signaling pathway, such as AKT phosphorylation. Technical limitations of exosome research: This study employed differential ultracentrifugation for exosome isolation, a widely used but nonspecific method that may result in co-isolation of other extracellular vesicles (e.g., microvesicles) or protein aggregates. Such contamination could affect the accuracy downstream analyses and the specificity of miRNA cargo attribution. To improve exosome purity and characterization, future studies should consider incorporating density gradient centrifugation or immunoaffinity-based isolation techniques, such as immunomagnetic beads targeting exosomal surface markers (e.g., CD63/CD81). Furthermore, the heterogeneity of ATMs, particularly the functional differences between M1 and M2 phenotypes, was not addressed. Emerging technologies such as single-cell RNA sequencing or single-vesicle analysis could be leveraged to identify which ATM subpopulations are the predominant source of miR-714-containing exosomes, providing greater resolution into the cellular origin and functional relevance of this miRNA. Furthermore, direct evidence confirming that miR-714 is specifically derived from ATM-derived exosomes, rather than from other cell types or non-exosomal components, remains to be established. In this study, we isolated exosomes from the culture supernatant of purified CD11b+F4/80+ ATMs, which ensures that the exosomes originate from ATMs; however, we did not perform exosome tracing experiments (e.g., PKH67 labeling combined with flow cytometry or fluorescence microscopy) to visualize the cellular source of exosomal miR-714, nor did we utilize macrophage-specific miR-714 knockout models (e.g., Lyz2-Cre-mediated conditional knockout) to unequivocally attribute the observed miR-714 changes to ATMs. Future studies employing such approaches, particularly ATM-specific miR-714 deletion or fluorescently labeled miR-714 tracing in vivo, will be essential to provide definitive evidence for the cell-type-specific origin and intercellular transfer of this exosomal miRNA. Limited clinical translatability and lack of human validation: The current study did not include validation using human samples, limiting its direct clinical applicability. Consequently, the expression profile of miR-714 in ATM-derived exosomes from individuals with obesity as well as its correlation with clinical parameters such as body mass index, and homeostatic model assessment for insulin resistance, remains uncharacterized. In addition, key translational aspects, such as the diagnostic specificity and sensitivity of exosomal miR-714, and the feasibility of therapeutic delivery systems for miR-714 inhibition (e.g., exosome-based carriers selectively targeting ATMs), require further investigation. Although our study establishes a mechanistically coherent axis linking ATM-derived exosomal miR-714 to adipocyte dysfunction via IGF1R suppression, it primarily relies on in vitro models. While these systems enable precise dissection of cell-autonomous effects, definitive validation of miR-714’s metabolic role in vivo—such as through adipose-specific or macrophage-specific miR-714 knockout in diet-induced obese mice—remains an essential next step. We are currently developing such genetic models to assess the therapeutic potential of targeting this pathway in whole-body metabolism. In summary, this study identifies a new molecular axis involved in obesity-related metabolic dysregulation and highlights miR-714/Igf1r as a potential therapeutic target. However, further investigations are needed to support its translational relevance, including cross-species validation, in-depth mechanistic analyses, and clinical confirmation. These steps are critical to advancing the miR-714/IGF1R axis as a viable target for intervention in the prevention and management of obesity-related metabolic disorders. Conclusion The findings of this study elucidate a regulatory mechanism by which ATM-derived exosomal miR-714 modulates adipocyte glucose and lipid metabolism through direct targeting of IGF1R. In an HFD-induced obesity model, miR-714 expression in ATM exosomes was significantly elevated, resulting in downregulation of IGF1R, reduced Glucose consumption, and increased TG accumulation in adipocytes. These findings reveal a pathway that could potentially contribute to metabolic dysfunction, and its differential regulation might offer a hypothetical explanation for the MNO phenotype. The miR-714/IGF1R axis thus represents a promising molecular target for the diagnosis, prevention, and treatment of obesity-related metabolic diseases. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Acknowledgements We would like to acknowledge the hard and dedicated work of all the staff that implemented the intervention and evaluation components of the study. Abbreviations Adipose tissue macrophages microRNA Insulin-like growth factor 1 receptor High-fat diet Triglyceride Normal control Wild type Mutant type Kyoto encyclopedia of genes and genomes Gene ontology Specific pathogen free 3-isobutyl-1-methylxanthine Quantitative real-time polymerase chain reaction Glucose Insulin Total cholesterol Low-density lipoprotein High-density lipoprotein Nanoparticle tracking analysis Phosphatidylinositol 3-kinase Protein kinase B Glucose transporter type 4 Peroxisome proliferator-activated receptor gamma Metabolically normal obesity Induced pluripotent stem cell Homeostasis model assessment of insulin resistance Author contributions Rui Ma and Sheng Jiang conceived the idea and conceptualized the study. Lei Li collected the data. Jing Yang and Lei Li analyzed the data and did the statistical analysis. Rui Ma obtained the funding and drafted the manuscript, then Rui Ma and Sheng Jiang reviewed the manuscript. All authors read and approved the final draft. Funding Natural Science Foundation of Xinjiang Uygur Autonomous Region, Youth Science Fund (No.2022D01C247). Data availability All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author. Declarations Ethics approval and consent to participate This study was conducted with approval from the Animal Care and Use Ethics Committee of The First Affiliated Hospital of Xinjiang Medical University. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. This study was conducted and reported in accordance with the ARRIVE guidelines 2.0. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Data Availability Statement All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.